Table 1 Flow cytometry data of... | American Society of Hematology

Table 1

Flow cytometry data of patient-derived primary ATLL cells

ID	Subtype	RHOA mutations	VAFs	CD25 (% of positive)	FOXP3 (% of positive)	PD1 (% of positive)
ATLL_A-02	Acute	C16R	0.12	43	26	0
ATLL_A-04	Acute	C16R	0.31	15	26	1
ATLL_A-03	Acute	C16G	0.14	44	64	21
ATLL_C-08	Chronic	A161V	0.42	42	36	16
ATLL_A-06	Acute	C16F	0.18	80	3	41
ATLL_C-06	Chronic	K118E	0.29	60	27	47
ATLL_A-13	Acute	A161P	0.04	63	8	73
ATLL_A-08	Acute	G17V	0.24	8	4	1
ATLL_A-01*	Acute	G17V	0.31	25	11	6
ATLL_A-20	Acute	WT	—	81	3	77
ATLL_A-66	Acute	WT	—	34	75	42
ATLL_C-42	Chrnoic	WT	—	23	21	6
Control	Carrier	WT	—	9	9	5

ID	Subtype	RHOA mutations	VAFs	CD25 (% of positive)	FOXP3 (% of positive)	PD1 (% of positive)
ATLL_A-02	Acute	C16R	0.12	43	26	0
ATLL_A-04	Acute	C16R	0.31	15	26	1
ATLL_A-03	Acute	C16G	0.14	44	64	21
ATLL_C-08	Chronic	A161V	0.42	42	36	16
ATLL_A-06	Acute	C16F	0.18	80	3	41
ATLL_C-06	Chronic	K118E	0.29	60	27	47
ATLL_A-13	Acute	A161P	0.04	63	8	73
ATLL_A-08	Acute	G17V	0.24	8	4	1
ATLL_A-01*	Acute	G17V	0.31	25	11	6
ATLL_A-20	Acute	WT	—	81	3	77
ATLL_A-66	Acute	WT	—	34	75	42
ATLL_C-42	Chrnoic	WT	—	23	21	6
Control	Carrier	WT	—	9	9	5

A case was analyzed by WGS.